Humacyte (HUMA) Shareholder's Equity (2020 - 2026)

Humacyte (HUMA) Shareholder's Equity (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 7.14 Bn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 795.79 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 595,226.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 14.38 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 19.36 Bn
9 Abivax 94.26 Bn 94.26 Bn - 502.95 Mn
10 Humacyte 267.09 Mn 218.55 Mn -1.54 Mn 11.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.62 Mn
Dec 31, 2025 3.11 Mn
Sep 30, 2025 -4.75 Mn
Jun 30, 2025 4.05 Mn
Mar 31, 2025 36.04 Mn
Dec 31, 2024 -52.67 Mn
Sep 30, 2024 -63.72 Mn
Jun 30, 2024 -28.29 Mn
Mar 31, 2024 26.15 Mn
Dec 31, 2023 13.55 Mn
Sep 30, 2023 36.99 Mn
Jun 30, 2023 61.12 Mn
Mar 31, 2023 81.89 Mn
Dec 31, 2022 116.93 Mn
Sep 30, 2022 118.67 Mn
Jun 30, 2022 142.26 Mn
Mar 31, 2022 103.89 Mn
Dec 31, 2021 122.17 Mn
Sep 30, 2021 75.86 Mn
Jun 30, 2021 -379.76 Mn